SNYNF — Sanofi

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1121404 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2027-01-28

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 15,233,000,000 11,601,000,000 4,705,000,000 3,021,000,000 130,287,000,000 5,966,000,000 57,046,000,000
Jun 2026 12,300,000,000 9,283,000,000 2,384,000,000 343,000,000 129,060,000,000 6,350,000,000 59,493,000,000
Mar 2026 11,244,000,000 8,106,000,000 2,269,000,000 1,614,000,000 128,024,000,000 5,544,000,000 54,881,000,000
Dec 2025 12,205,000,000 8,449,000,000 1,630,000,000 -801,000,000 126,805,000,000 7,657,000,000 55,095,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$11,957,000,000
Investing CF
$-4,871,000,000
Financing CF
$-9,615,000,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$3.49
As of
2026-11-08

Yahoo Snapshot (yfinance, live)

Total Revenue
$48,918,999,040
EBITDA
$13,543,000,064
Free Cash Flow
$6,298,999,808
Enterprise Value
$118,247,759,872
Total Cash
$6,350,000,128
Total Debt
$23,576,000,512
Shares Out
1,198,068,685
Trailing EPS
$3.77
Book Value
$67.20
ROE
5.7%
ROA
5.1%
Div Yield
5.76%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 46,716,000,000 9,597,000,000 7,813,000,000 126,805,000,000 55,095,000,000 71,376,000,000 10,750,000,000
Dec 2024 44,286,000,000 8,923,000,000 5,560,000,000 132,798,000,000 54,941,000,000 77,507,000,000 9,081,000,000
Dec 2023 41,618,000,000 8,691,000,000 5,400,000,000 126,464,000,000 52,111,000,000 74,040,000,000 10,258,000,000
Dec 2022 40,561,000,000 10,926,000,000 8,371,000,000 127,000,000,000 51,600,000,000 74,784,000,000 10,526,000,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$9.25

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.26T $1415.55 —
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
ABBV AbbVie Inc. $517.59B $292.82 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —

News headlines (Yahoo Finance, 1h cache)

Jacobs selected by Sanofi to deliver new insulin manufacturing facility in Germany
2026-11-19 08:30 · Yahoo
Sanofi (ENXTPA:SAN) Wins FDA Approval For First Type 3 Gaucher Brain Therapy
2026-11-19 06:15 · Yahoo
Press Release: Sanofi’s next-generation rabies vaccine, VaxRabeo, approved in the EU for all ages
2026-11-19 06:00 · Yahoo
Press Release: Sanofi’s Infilbray approved in the US as the first medicine to treat neurological manifestations of Type 3 Gaucher disease
2026-11-18 22:19 · Yahoo
Regeneron Wins EC Clearance for Libtayo Dosing Flexibility
2026-11-18 18:10 · Yahoo
Global Medical Countermeasures Market 2026: Size, Trends, and Forecast to 2030 | Capitalize on AI, Stockpiling, and Rapid Diagnostics with Pfizer, Moderna, Sanofi, and Emergent
2026-11-18 14:36 · Yahoo
Allergy Clinical Trial Services Global Market Report 2026: $1.66 Billion Forecast to 2030 | Capitalize on AI and Remote Trials with J&J, Merck, Sanofi, Novartis, and GSK
2026-11-18 14:35 · Yahoo
Novavax Eyes New Partnerships as Sanofi Advances COVID-Flu Vaccine Trial
2026-11-17 21:12 · Yahoo
Seawolf Therapeutics and Sanofi agree $1.2bn drug deal
2026-11-17 12:15 · Yahoo
Sanofi and the pan-Canadian Pharmaceutical Alliance sign Letter of Intent for Sarclisa®(isatuximab), a step toward public access for newly diagnosed, transplant-ineligible multiple myeloma patients
2026-11-16 14:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.